Categories
Ailmemts & Remedies

Endometrial cancer

Alternative Names:- Endometrial adenocarcinoma; Uterine adenocarcinoma; Uterine cancer; Adenocarcinoma -endometrium; Adenocarcinoma – uterus; Cancer – uterine; Cancer – endometrial; Uterine corpus cancer

Definition:
The endometrium is the tissue lining the uterus (or womb). The uterus, a hollow organ about the size and shape of a pear, is found in a woman’s pelvic region and is the organ where the fetus grows until birth. The upper part of the uterus is called the corpus; the lower, narrower part of the uterus is called the cervix. The cervix is the opening between the uterus and the vagina. The outer layer of the uterus is called the myometrium. The myometrium is thick and composed of strong muscles. These muscles contract during labor to push out the baby.

The endometrium is soft and spongy. Each month, the endometrium changes as part of the menstrual cycle. Early in the cycle, the ovaries secrete a hormone called estrogen that causes the endometrium to thicken. In the middle of the cycle, the ovaries start secreting another hormone called progesterone. Progesterone prepares the innermost layer of the endometrium to support an embryo should conception (pregnancy) occur. If conception does not occur, the hormone levels decrease dramatically. The innermost layer of the endometrium is then shed as menstrual fluid. This leads to the cyclical nature of the menstrual cycle.

CLICK & SEE THE PICTURES

Endometrial cancer occurs when cells of the endometrium undergo a transformation and begin to grow and multiply without the control mechanisms that normally limit their growth. As the cells grow and multiply, they form a mass called a tumor. Cancer is dangerous because it overwhelms healthy cells by taking their space and the oxygen and nutrients they need to survive and function.


Not all tumors are cancerous; however, cancerous tumors are called malignant, meaning they can spread to other tissues and organs. Cancerous tumors may encroach on and invade neighboring organs or lymph nodes, or they may enter the bloodstream and spread to the bones or distant organs, such as the lungs. This process is called metastasis. Metastatic tumors are the most aggressive and serious of all tumors.

Two main types of endometrial cancers exist. Nearly all endometrial cancers are endometrial adenocarcinomas, meaning they originate from glandular (secreting) tissue. The other type of endometrial cancer, uterine sarcomas, originates in the connective tissue or muscle of the uterus. A subtype of endometrial adenocarcinomas, adenosquamous carcinoma, includes squamous cells (that is, the type of cells found on the surface of the skin and cervix). Other subtypes of endometrial adenocarcinomas are papillary serous adenocarcinomas and clear cell carcinomas.

Endometrial cancer is often detected at an early stage because it frequently produces abnormal vaginal bleeding, which prompts women to see their doctors. If endometrial cancer is discovered early, removing the uterus surgically often eliminates all of the cancer.

In developed countries, uterine cancer is the most common cancer of the female genital tract. In the United States, uterine cancer is the fourth most common cancer in women. Uterine cancer was diagnosed in about 42,160 women in the United States in 2009, and about 7,800 women died of the disease. Uterine cancer occurs in women of reproductive age and older. About one-quarter of cases occur before menopause, but the disease is most often diagnosed in women in their 50s or 60s.

Symptoms:
Signs and symptoms of endometrial cancer may include:

*Prolonged periods or bleeding between periods
*An abnormal, watery or blood-tinged discharge from your vagina
*Pain during intercourse
*Abnormal uterine bleeding, abnormal menstrual periods
*Bleeding between normal periods before menopause
*Vaginal bleeding or spotting after menopause
*Extremely long, heavy, or frequent episodes of vaginal bleeding after age 40
*Lower abdominal pain or pelvic cramping
*Thin white or clear vaginal discharge after menopause

Causes & Risk Factors:
Endometrial cancer is the most common type of uterine cancer. Although the exact cause of endometrial cancer is unknown, increased levels of estrogen appear to play a role. Estrogen helps stimulate the buildup of the lining of the uterus. Studies have shown that high levels of estrogen in animals result in excessive endometrial growth and cancer.

Most cases of endometrial cancer occur between the ages of 60 and 70 years, but a few cases may occur before age 40.

The following increase your risk of endometrial cancer:

•Diabetes
•Estrogen replacement therapy without the use of progesterone
•History of endometrial polyps or other benign growths of the uterine lining
•Infertility (inability to become pregnant)
•Infrequent periods
•Tamoxifen, a drug for breast cancer treatment
•Never being pregnant
•Obesity
•Polycystic ovarian syndrome (PCOS)
•Starting menstruation at an early age (before age 12)
•Starting menopause after age 50

Associated conditions include the following:
•Colon or breast cancer
•Gallbladder disease
•High blood pressure
•Polycystic ovarian disease

Complecations:
Endometrial cancer can spread to other parts of your body, making it more difficult to treat successfully. Endometrial cancer that spreads (metastasizes) most often travels to the lungs.

Diagnosis:
A pelvic examination is frequently normal, especially in the early stages of disease. Changes in the size, shape, or feel of the uterus or surrounding structures may be seen when the disease is more advanced.

Tests that may be done include:

•Endometrial aspiration or biopsy
•Dilation and curettage (D and C)
•Pap smear (may raise a suspicion for endometrial cancer, but does not diagnose it)….

If cancer is found, other tests may be done to determine how widespread the cancer is and whether it has spread to other parts of the body. This is called staging.

Stages of endometrial cancer:

1.The cancer is only in the uterus...….

2.The cancer is in the uterus and cervix.
3.The cancer has spread outside of the uterus but not beyond the true pelvis area. Cancer may involve the lymph nodes in the pelvis or near the aorta (the major artery in the abdomen).
4.The cancer has spread to the inner surface of the bowel, bladder, abdomen, or other organs.
Cancer is also described as Grade 1, 2, or 3. Grade 1 is the least aggressive, and grade 3 is the most aggressive.

Treatment:
Treatment options involve surgery, radiation therapy, and chemotherapy.

A hysterectomy may be performed in women with the early stage 1 disease. Removal of the tubes and ovaries (bilateral salpingo-oophorectomy) is also usually recommended.

Abdominal hysterectomy is recommended over vaginal hysterectomy. This type of hysterectomy allows the surgeon to look inside the abdominal area and remove tissue for a biopsy.

Surgery combined with radiation therapy is often used to treat women with stage 1 disease that has a high chance of returning, has spread to the lymph nodes, or is a grade 2 or 3. It is also used to treat women with stage 2 disease.

Chemotherapy may be considered in some cases, especially for those with stage 3 and 4 disease.

Coping & Support:
After you receive a diagnosis of endometrial cancer, you may have many questions, fears and concerns. How will the diagnosis affect you, your family, your work and your future? You may worry about tests, treatments, hospital stays and medical bills. Even if a full recovery is likely, you may worry about possible recurrence of your cancer.

Fortunately, many resources are available to help answer questions and provide support. The key is to remember that you don’t have to face your questions or fears alone.  Some strategies and resources are given below that may make dealing with endometrial cancer easier:

*Know what to expect. Find out enough about your cancer so that you feel comfortable making decisions about your care. Ask your doctor for information about the stage, your treatment options and their side effects. In addition to talking with your doctor, look for information in your local library and on the Internet. Staff of the National Cancer Institute (NCI) will answer questions from the public. You can reach the NCI at 800-4-CANCER (800-422-6237). Or contact the American Cancer Society at 800-227-2345.

*Be proactive. Although you may feel tired and discouraged, try to take an active role in your treatment. Before starting treatment, you might want a second opinion from a qualified specialist. Many insurance companies will pay for such consultations.

*Maintain a strong support system. Strong relationships may help you cope with treatment. Talk with your close friends and family members about how you’re feeling. Connect with other cancer survivors through support groups in your community or online. Ask your doctor about support groups in your area

Prognosis:
Endometrial cancer is usually diagnosed at an early stage. The 1-year survival rate is about 92%.

The 5-year survival rate for endometrial cancer that has not spread is 95%. If the cancer has spread to distant organs, the 5-year survival rate drops to 23%.

Prevention:
To reduce your risk of endometrial cancer, you may wish to:

*Talk to your doctor about the risks of hormone therapy after menopause. If you’re considering hormone replacement therapy to help control menopause symptoms, talk to your doctor about the risks and benefits. Unless you’ve undergone a hysterectomy, replacing estrogen alone after menopause may increase your risk of endometrial cancer. Taking a combination of estrogen and progestin can reduce this risk. Hormone therapy carries other risks, such as a possible increase in the risk of breast cancer, so weigh the benefits and risks with your doctor.

*Consider taking birth control pills. Using oral contraceptives for at least one year may reduce endometrial cancer risk. The risk reduction is thought to last for several years after you stop taking oral contraceptives. Oral contraceptives have side effects, though, so discuss the benefits and risks with your doctor.

*Maintain a healthy weight. Obesity increases the risk of endometrial cancer, so work to achieve and maintain a healthy weight. If you need to lose weight, increase your physical activity and reduce the number of calories you eat each day.

*Exercise most days of the week. Work physical activity into your daily routine. Try to exercise 30 minutes most days of the week. If you can exercise more, that’s even better.

Disclaimer: This information is not meant to be a substitute for professional medical advise or help. It is always best to consult with a Physician about serious health concerns. This information is in no way intended to diagnose or prescribe remedies.This is purely for educational purpose.

Resources:
http://www.nlm.nih.gov/medlineplus/ency/article/000910.htm
http://www.mayoclinic.com/health/endometrial-cancer/DS00306
http://www.bbc.co.uk/health/physical_health/conditions/in_depth/cancer/womb_cancer.shtml
http://www.emedicinehealth.com/endometrial_cancer/article_em.htm
http://health.allrefer.com/health/endometrial-cancer-endometrial-cancer.html

http://mesotheliomaz.info/endometrial-cancer.html

http://www.medicalook.com/Cancer/Endometrial_carcinoma.html

http://familydoctor.org/online/famdocen/home/women/reproductive/gynecologic/138.html

Enhanced by Zemanta
Categories
Herbs & Plants

Adder’s Tongue

[amazon_link asins=’B01JYD68BI,B01JYMMZ48,B01JYCVIYQ,B01JYK7770,B01J8V943K,B01J2FYV6W,B0722S4NS9,B01IWIGMP8,B01JV27IX4′ template=’ProductCarousel’ store=’finmeacur-20′ marketplace=’US’ link_id=’84819feb-5705-11e7-b810-635f009ede27′]

Botanical Name : Ophioglossum vulgatum
Family: Ophioglossaceae
Genus: Ophioglossum
Species: O. vulgatum
Kingdom: Plantae
Division: Pteridophyta
Class: Psilotopsida
Order: Ophioglossales
Common Name :Southern adderstongue,Adder’s Tongue

Habitat : Adder’s Tongue  is native to temperate regions of the Northern Hemisphere, with a scattered distribution in Europe, Asia, northwestern Africa, and eastern North America.This small, hard-to-spot plant occurs singly in un-improved pastures, rock crevices and grassy path-sides but also occurs in colonies of hundreds of plants in sand dune slacks.

Description:
This plant grows from a rhizome base to 10-20 cm tall (rarely to 30 cm). It consists of a two-part frond, separated into a rounded diamond-shaped sheath and narrow spore-bearing spike. The spike has around 10-40 segments on each side. It reproduces by means of spores.It is basicaly a fern.

click to see…>..(01)...(1).……..(2).……..(3).……..…(4)....

It is hardy to zone 5. The seeds ripen from May to August. The plant prefers light (sandy), medium (loamy) and heavy (clay) soils and requires well-drained soil.The plant prefers acid, neutral and basic (alkaline) soils..It cannot grow in the shade.It requires moist soil.

Cultivation:
Prefers a moist free-draining soil. Plants are hardy to about -15°c[200]. The prothalli (a small plant formed when the spore germinates) of this species form a symbiotic relationship with a mycorrhizal fungus in much the same way as orchid seedlings. Members of this genus are rarely if ever troubled by browsing deer. Plants can be hard to establish, they can be naturalized in a meadow or cultivated in the border where they should be left undisturbed. Unlike most species of ferns, the fronds of this species grow up straight and not curled inward, crozier fashion.

Propagation:
Spores – best sown as soon as they are ripe on the surface of a humus-rich sterilized soil. Keep the compost moist, preferably by putting a plastic bag over the pot. Pot on small clumps of plantlets as soon as they are large enough to handle and keep them in humid conditions until they are well established. Do not plant outside until the ferns are at least 2 years old. Division of underground rhizomes with care because the roots are brittle

Edible Uses: The leaves used as a vegetable.

Medicinal Uses:
Emetic;  Skin;  Vulnerary.

The root and the leaves are antiseptic, detergent, emetic, haemostatic, styptic and vulnerary. An ointment made from the plant is considered to be a good remedy for wounds and is also used in the treatment of skin ulcers. The expressed juice of the leaves is drunk as a treatment for internal bleeding and bruising

Generally used as a poultice for ulcers and skin troubles.  An infusion of the leaves is taken for the relief of skin problems and for enlarged glands.  Various oil infusions and ointments made from the leaf and spike have been used to treat wounds, and poultices of the fresh leaves have been applied to soothe and heal bruises.  The bulbs of the plant have been recorded as emetic and as a substitute for Colchicium in the treatment of gout.  In the fresh state it has been reported to be a remedy for scurvy.  It is often used to treat scrofulous skin arising from tubercular infection.  Can mix the expressed juice with cider for internal use.  Must be used fresh.

Traditional European folk use of leaves and rhizomes as a poultice for wounds. This remedy was sometimes called the “Green Oil of Charity”. A tea made from the leaves was used as a traditional European folk remedy for internal bleeding and vomiting.

Disclaimer:
The information presented herein is intended for educational purposes only. Individual results may vary, and before using any supplements, it is always advisable to consult with your own health care provider.

Resources:
http://en.wikipedia.org/wiki/Ophioglossum_vulgatum
http://www.pfaf.org/user/Plant.aspx?LatinName=Ophioglossum%20vulgatum
http://www.hlasek.com/ophioglossum_vulgatum_8593.html
http://www.nature-diary.co.uk/2008/05-18.htm

http://species.wikimedia.org/wiki/Ophioglossum_vulgatum

http://www.herbnet.com/Herb%20Uses_AB.htm

Enhanced by Zemanta
Categories
Exercise

On the Strong and Balanced Side

When your core is strong, daily activities become easier and you’ll get more from your exercise routines as well. Remember to incorporate this straightforward yet challenging move for a more balanced practice.
CLICK & SEE 

Begin on your hands and knees. Turn to the side and position your right hand directly below your right shoulder and your right knee below your right hip. Straighten your left leg with your left foot flat on the floor, toes and knee facing forward. Reach up with your left arm so it is above your shoulders. Engage your abdominals and move your tailbone in toward your body to avoid over-arching your lower back. Look up to the ceiling and pause.

Keeping your hips and shoulders stacked, push through your left heel and lift it to hip level. Concentrate on maintaining your balance with minimal movement in your torso. Hold this position for three to six breaths. Then lower your leg, come to all fours and repeat on the other side.

Source:Los Angeles Times

Enhanced by Zemanta
Categories
Herbs & Plants

Argyi wormwood(Artemisia argyi)

[amazon_link asins=’B00408LAXO,B06XFNVLH5,B01EG3QHPI,B013XMN41S,B01FRN9PIC,B00QCRW9HC,B00RY81T6U,B00HKTEULY,B01HBXN8BG’ template=’ProductCarousel’ store=’finmeacur-20′ marketplace=’US’ link_id=’016041ce-1e72-11e7-8327-d7baac1035bd’][amazon_link asins=’B06XFNVLH5,B01MQM8AUG,B013XMN41S,B01G6R3LX8,B008X8LVQS,B01LJB6MQO,B008X8LWG2,B008X8LXIE’ template=’ProductCarousel’ store=’finmeacur-20′ marketplace=’US’ link_id=’bd052cab-1e71-11e7-894c-336da4f5dc90′]

 

Botanical Name : Artemisia argyi
Family: Asteraceae
Genus: Artemisia
Species: A. argyi
Kingdom: Plantae
Order: Asterales
Commopn Names:Argyi wormwood, In Japan it is known as Gaiyou and in China as Ai Ye.

Habitat :Argyi wormwood   is native to China, Japan and the far east parts of the former Soviet Union.This wormwood is a xerophile, growing on dry mountain slopes, steep river banks, the edges of oak woods, coastal scrub, wasteland and along road and railway verges. The plants do better and are more aromatic when they grow on poor dry soil.It grows on waste places, roadsides, slopes, hills, steppe and forest steppe at low elevations to 1500 metres in most areas of China.

Description:
Argyi wormwood is an upright, greyish, herbaceous perennial about one metre tall, with short branches and a creeping rhizome. The stalked leaves are ovate, deeply divided and covered in small, oil-producing glands, pubescent above and densely white tomentose below. The lower leaves are about six centimetres long, bipinnate with wide lanceolate lobes and short teeth along the margins. The upper leaves are smaller and three-partite, and the bracteal leaves are simple, linear and lanceolate. The inflorescence is a narrow leafy panicle. The individual flowers are pale yellow, tubular, and clustered in spherical turned-down heads. The central flowers are bisexual while the marginal flowers are female. The petals are narrow and folded cylindrically and the bracts have a cobwebby pubescence. The whole plant is strongly aromatic.

CLICK & SEE THE PICTURES
Propagation:
Seed – surface sow spring in a greenhouse. Do not allow the compost to dry out. When large enough to handle, prick the seedlings out into individual pots and plant them out in early summer.

Medicinal use:
Argyi wormwood is used in herbal medicine for conditions of the liver, spleen and kidney.
Wormwood leaves are gathered on a warm dry day in spring and summer when the plant is in flower and dried in the shade. In traditional Chinese medicine, they are considered to have bitter, pungent and warm properties and to be associated with the liver, spleen and kidney meridians. The leaves are used as an antiseptic, expectorant, febrifuge and styptic.  The herb is considered to increase the blood supply to the pelvic region and stimulate menstruation, help treat infertility, dysmenorrhea, asthma and coughs. Another use is in moxibustion, a form of healing in which the herb is burned in cones or sticks or on the tip of an acupuncture needle. Boiling water can be poured onto the ground up leaves and used in a decoction, alone or with other substances, and the fresh leaf can be crushed and blended and a juice extracted. A volatile oil can be extracted from the leaves and used in the treatment of asthma and bronchitis for which purpose it is sprayed onto the back of the throat and brings rapid relief. The leaves have an antibacterial action and have been shown to be effective against Staphylococcus aureus, Bacillus dysenteriae, Bacillus subtilis, Bacillus typhi, Escherichia coli and Pseudomonas.

The leaves have been found to have an antibacterial action, effective against Staphylococcus aureus, Bacillus typhi, B. dysenteriae, E. coli, B. subtilis, Pseudomonas etc.    The leaf stalks used to treat chronic dysentery, eye disease. Seeds are used to treat sweating at night, excessive gas in the system, tuberculosis, indigestion

Research:
*Ninety six volatile constituents have been identified from the leaves of A. argyi and certain other species of wormwood including alpha-thujene, 1,8-cineole, camphor and artemisia alcohol.

*Nearly fifty volatile constituents have been identified from A. argyi flowers and it is suggested that therapeutic use of the flowers may be just as effective as using the leaves.

*A methanol extract prepared from aerial parts of the plant strongly reduced the mutagenicity of Salmonella typhimurium.

*An extract of A. argyiwas shown to have antifungal activity against Botrytis cinerea and Alternaria alternata which cause deterioration of fruit and vegetables in storage.

*Flavones isolated from an extra of the herb were shown to have an anti-tumour effect.

*A study examined the clinical efficacy of moxibustion, analyzed the chemical compositions of the leaf of different strains of A. argyi, examined the best mode of delivery and how to enhance the therapeutic effects of this treatment.
Known Hazards : Although no reports of toxicity have been seen for this species, skin contact with some members of this genus can cause dermatitis or other allergic reactions in some people.

Disclaimer:
The information presented herein is intended for educational purposes only. Individual results may vary, and before using any supplements, it is always advisable to consult with your own health care provider.

Resources:
http://en.wikipedia.org/wiki/Artemisia_argyi
http://www.herbnet.com/Herb%20Uses_AB.htm
http://www.pfaf.org/user/Plant.aspx?LatinName=Artemisia%20argyi

http://www.fzrm.com/plantextracts/plantextract/artemisia%20argyi%20Levl.%20et%20Vant..htm

http://www.asiancancerherb.info/Ai.htm

http://www.pfaf.org/user/Plant.aspx?LatinName=Artemisia+argyi

Enhanced by Zemanta
Categories
Therapetic treatment

Electro-Convulsive Therapy

[amazon_link asins=’B005H5T94Q,B00F8KAPHA,0062213792,B00A92V7AQ,0275968154,B0070OB3CS,0849359406,B01LY8ZGDB’ template=’ProductCarousel’ store=’finmeacur-20′ marketplace=’US’ link_id=’37e23d74-1e75-11e7-a4ae-5564dc6a10da’]

Definition:
Electroconvulsive therapy (ECT) is a procedure in which electric currents are passed through the brain, deliberately triggering a brief seizure. Electroconvulsive therapy seems to cause changes in brain chemistry that can immediately reverse symptoms of certain mental illnesses. It often works when other treatments are unsuccessful.

click to see

Electroconvulsive therapy (ECT), formerly known as electroshock, is a psychiatric treatment in which seizures are electrically induced in anesthetized patients for therapeutic effect. Its mode of action is unknown. Today, ECT is most often recommended for use as a treatment for severe depression which has not responded to other treatment, and is also used in the treatment of mania and catatonia. It was first introduced in the 1938 and gained widespread use as a form of treatment in the 1940s and 1950s.

click to see

Informed consent is a standard of modern electroconvulsive therapy. According to the Surgeon General, involuntary treatment is uncommon in the United States and is typically only used in cases of great extremity, and only when all other treatment options have been exhausted and the use of ECT is believed to be a potentially life saving treatment. However, caution must be exercised in interpreting this assertion as, in an American context, there does not appear to have been any attempt to survey at national level the usage of ECT as either an elective or involuntary procedure in almost twenty years. In one of the few jurisdictions where recent statistics on ECT usage are available, a national audit of ECT by the Scottish ECT Accreditation Network indicated that 77% of patients who received the treatment in 2008 were capable of giving informed consent

click to see

Electroconvulsive therapy can differ in its application in three ways: electrode placement, frequency of treatments, and the electrical waveform of the stimulus. These three forms of application have significant differences in both adverse side effects and positive outcomes. After treatment, drug therapy is usually continued, and some patients receive continuation/maintenance ECT. In the United Kingdom and Ireland, drug therapy is continued during ECT.

click to see

The treatment involves placing electrodes on the temples, on one or both sides of the patient’s head, and delivering a small electrical current across the brain, with the patient sedated or under anaesthetic. The aim is to produce a seizure lasting up to a minute, after which the brain activity should return to normal. Patients may have one or more treatment a week, and perhaps more than a dozen treatments in total.

Although ECT has been used since the 1930s, there is still no generally accepted theory to explain how it works. One of the most popular ideas is that it causes an alteration in how the brain responds to chemical signals or neurotransmitters.

Why & when it is done?
Electroconvulsive therapy (ECT) can provide rapid, significant improvements in severe symptoms of a number of mental health conditions. It may be an effective treatment in someone who is suicidal, for instance, or end an episode of severe mania.

ECT is used to treat:
*Severe depression, particularly when accompanied by detachment from reality (psychosis), a desire to commit suicide or refusal to eat.

*Treatment-resistant depression, long-term depression that doesn’t improve with medications or other treatments.

*Schizophrenia, particularly when accompanied by psychosis, a desire to commit suicide or hurt someone else, or refusal to eat.

*Severe mania, a state of intense euphoria, agitation or hyperactivity that occurs as part of bipolar disorder. Other signs of mania include impaired decision making, impulsive or risky behavior, substance abuse and psychosis.

click to see

*Catatonia, characterized by lack of movement, fast or strange movements, lack of speech, and other symptoms. It’s associated with schizophrenia and some other psychiatric disorders. In some cases, catatonia is caused by a medical illness.

Electroconvulsive therapy is sometimes used as a last-resort treatment for:

#Treatment-resistant obsessive compulsive disorder, severe obsessive compulsive disorder that doesn’t improve with medications or other treatments

#Parkinson’s disease, epilepsy, and certain other conditions that cause movement problems or seizures

*Tourette syndrome that doesn’t improve with medications or other treatments

ECT may be a good treatment option when medications aren’t tolerated or other forms of therapy haven’t worked. In some cases ECT is used:

#During pregnancy, when medications can’t be taken because they might harm the developing fetus

#In older adults who can’t tolerate drug side effects

#In people who prefer ECT treatments over taking medications

#When ECT has been successful in the past

Risk factor:
Patients are given short-acting anaesthetics, muscle relaxants and breathe pure oxygen during the short procedure in order to minimise the risks. However, although ECT is much safer than it was, there are still side effects to the treatment. The most common are headache, stiffness, confusion and temporary memory loss on awaking from the treatment – some of these can be reduced by placing electrodes only on one side of the head. Memory loss can be permanent in a few cases, and the spasms associated with the seizure can cause fractured vertebrae and tooth damage. However, the recommended use of muscle relaxant nowadays makes the latter a very rare occurrence. Patients can also experience numbness in the fingers and toes.

The death rate from ECT used to be quoted as one for every 1,000 patients, but with smaller amounts of electric current used in modern treatments, accompanied by more safety techniques, this has been reduced to as little as four or five in 100,000 patients.

Recomendations:
A common argument against ECT is that it destroys brain cells, with experiments conducted on animals in the 1940s often cited as evidence. However, modern studies have yet to reproduce these findings in the human brain.

Some activists, however, still campaign against the widespread use of ECT in psychiatry, quoting those cases which have resulted in long-term damage or even death, whether because of the built-in chance of problems, or through errors by doctors.

Experts say that given the correct staff training, and when used for the right clinical conditions, ECT can ‘dramatically’ benefit the patient. An audit of ECT in Scotland between February 1996 and August 1999 said concerns about unacceptable side effects, effectiveness of the treatment and disproportionate use on elderly people were ‘largely without foundation’.

It said that in nearly three quarters of cases people with depressive illness showed ‘a definite improvement’ after ECT. Women were more likely to receive the treatment than men, but the auditors said this was because they were twice as likely to suffer from depression. Only 12 per cent of patients who got ECT were aged over 75. However, the Royal College of Psychiatrists has admitted that in the past the treatment has been administered by untrained, unsupervised junior doctors. However, modern guidelines have changed this and ECTAS (ECT Accreditation Services) exist to check that such treatment is being given safely and efficiently.

Guidelines on ECT from NICE (2003) recommend that it’s used only to achieve rapid and short-term improvement of severe symptoms after an adequate trial of other treatment. options has proven ineffective and/or when the condition is considered to be potentially life-threatening, in individuals with:

•Severe depressive illness
•Catatonia
•Prolonged or severe manic episode

NICE also says that ‘valid consent should be obtained in all cases where the individual has the ability to grant or refuse consent. The decision to use ECT should be made jointly by the individual and the clinician(s) responsible for treatment, on the basis of an informed discussion. This discussion should be enabled by the provision of full and appropriate information about the general risks associated with ECT and about the risks and potential benefits specific to that individual. Consent should be obtained without pressure or coercion, which may occur as a result of the circumstances and clinical setting, and the individual should be reminded of their right to withdraw consent at any point. There should be strict adherence to recognised guidelines about consent and the involvement of patient advocates and/or carers to facilitate informed discussion is strongly encouraged.’

 

Click to learn more  in detail  about  Electro-Convulsive Therapy

You may click to see:-

Keep fighting even when depression treatments don’t work
Video:Electroconvulsive therapy

DSM-IV Codes
Harold A. Sackeim
Insulin shock therapy
History of electroconvulsive therapy in the United Kingdom
Psychiatric survivors movement
Consumer/Survivor/Ex-Patient Movement
List of people who have undergone electroconvulsive therapy

 

Resources:
http://www.mayoclinic.com/health/electroconvulsive-therapy/MY00129
http://www.bbc.co.uk/health/physical_health/conditions/electro_convulsive_therapy.shtml
http://en.wikipedia.org/wiki/Electroconvulsive_therapy

http://www.minddisorders.com/Del-Fi/Electroconvulsive-therapy.html

Enhanced by Zemanta
css.php